| 注册
首页|期刊导航|中国药物经济学|我国实施分级诊疗政策的SWOT分析

我国实施分级诊疗政策的SWOT分析

李相荣 田进芳 李向伶 王彩 汤榕

中国药物经济学2019,Vol.14Issue(2):11-14,4.
中国药物经济学2019,Vol.14Issue(2):11-14,4.DOI:10.12010/j.issn.1673-5846.2019.02.002

我国实施分级诊疗政策的SWOT分析

SWOT Analysis of Implementing Hierarchical Diagnosis and Treatment Policy in China

李相荣 1田进芳 1李向伶 1王彩 1汤榕1

作者信息

  • 1. 宁夏医科大学公共卫生与管理学院, 宁夏银川 750004
  • 折叠

摘要

Abstract

The implementation of the hierarchical diagnosis and treatment policy is an important part of China's deepening of the reform of the medical and health system, and is of great significance to the development of China's health industry. This paper used SWOT analysis to analyze the hierarchical diagnosis and treatment policies implemented in China from 4 aspects: advantages, disadvantages, opportunities and threats. Based on the analysis results, this paper constructed a SWOT matrix, deeply explored the response plan, and proposed to promote the implementation of the hierarchical diagnosis and treatment policy.

关键词

分级诊疗/SWOT分析/政策建议

Key words

Hierarchical diagnosis and treatment/SWOT analysis/Policy recommendations

分类

医药卫生

引用本文复制引用

李相荣,田进芳,李向伶,王彩,汤榕..我国实施分级诊疗政策的SWOT分析[J].中国药物经济学,2019,14(2):11-14,4.

基金项目

国家社会科学基金(15BGL188) (15BGL188)

宁夏自然科学基金(NZ17089) (NZ17089)

宁夏医科大学研究生创新创业项目(YJSCXCY2018003) (YJSCXCY2018003)

中国药物经济学

1673-5846

访问量0
|
下载量0
段落导航相关论文